Effect of fibrinogen concentration and platelet count on the inhibitory effect of abciximab and tirofiban

Giulia Renda, Bianca Rocca, Roberto Crocchiolo, Raimondo De Cristofaro, Raffaele Landolfi

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Glycoprotein (Gp) IIb/IIIa blockers are powerful antithrombotic agents, but display a wide variability of their effect using weight-adjusted dosing. We investigated whether some hemostatic variables affected in vitro platelet inhibition exerted by the antibody abciximab and the peptidomimetic tirofiban. High fibrinogen concentrations reduced platelet inhibition by tirofiban, assessed in whole blood (r = -0.85, n= 10, p <0.01) and in platelet rich plasma (r = -0.89, n = 10, p <0.01) through PFA 100 and Born's aggregometry assay, respectively. Both drugs were unaffected by von Willebrand factor levels, while platelet count was inversely related to their inhibitory effect (tirofiban: r = -0.9, n = 7, p

Original languageEnglish
Pages (from-to)348-354
Number of pages7
JournalThrombosis and Haemostasis
Volume89
Issue number2
Publication statusPublished - Feb 1 2003

Fingerprint

tirofiban
Platelet Count
Fibrinogen
Blood Platelets
Peptidomimetics
Platelet Glycoprotein GPIIb-IIIa Complex
Platelet-Rich Plasma
Fibrinolytic Agents
von Willebrand Factor
Hemostatics
Weights and Measures
Antibodies
Pharmaceutical Preparations
abciximab

Keywords

  • Fibrinogen
  • GpIIb-IIIa blockers
  • Inhibition
  • Platelet
  • Receptor occupancy

ASJC Scopus subject areas

  • Hematology

Cite this

Effect of fibrinogen concentration and platelet count on the inhibitory effect of abciximab and tirofiban. / Renda, Giulia; Rocca, Bianca; Crocchiolo, Roberto; De Cristofaro, Raimondo; Landolfi, Raffaele.

In: Thrombosis and Haemostasis, Vol. 89, No. 2, 01.02.2003, p. 348-354.

Research output: Contribution to journalArticle

Renda, Giulia ; Rocca, Bianca ; Crocchiolo, Roberto ; De Cristofaro, Raimondo ; Landolfi, Raffaele. / Effect of fibrinogen concentration and platelet count on the inhibitory effect of abciximab and tirofiban. In: Thrombosis and Haemostasis. 2003 ; Vol. 89, No. 2. pp. 348-354.
@article{aba1cec43a1d487c801da8e54f8aee49,
title = "Effect of fibrinogen concentration and platelet count on the inhibitory effect of abciximab and tirofiban",
abstract = "Glycoprotein (Gp) IIb/IIIa blockers are powerful antithrombotic agents, but display a wide variability of their effect using weight-adjusted dosing. We investigated whether some hemostatic variables affected in vitro platelet inhibition exerted by the antibody abciximab and the peptidomimetic tirofiban. High fibrinogen concentrations reduced platelet inhibition by tirofiban, assessed in whole blood (r = -0.85, n= 10, p <0.01) and in platelet rich plasma (r = -0.89, n = 10, p <0.01) through PFA 100 and Born's aggregometry assay, respectively. Both drugs were unaffected by von Willebrand factor levels, while platelet count was inversely related to their inhibitory effect (tirofiban: r = -0.9, n = 7, p",
keywords = "Fibrinogen, GpIIb-IIIa blockers, Inhibition, Platelet, Receptor occupancy",
author = "Giulia Renda and Bianca Rocca and Roberto Crocchiolo and {De Cristofaro}, Raimondo and Raffaele Landolfi",
year = "2003",
month = "2",
day = "1",
language = "English",
volume = "89",
pages = "348--354",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Schattauer GmbH",
number = "2",

}

TY - JOUR

T1 - Effect of fibrinogen concentration and platelet count on the inhibitory effect of abciximab and tirofiban

AU - Renda, Giulia

AU - Rocca, Bianca

AU - Crocchiolo, Roberto

AU - De Cristofaro, Raimondo

AU - Landolfi, Raffaele

PY - 2003/2/1

Y1 - 2003/2/1

N2 - Glycoprotein (Gp) IIb/IIIa blockers are powerful antithrombotic agents, but display a wide variability of their effect using weight-adjusted dosing. We investigated whether some hemostatic variables affected in vitro platelet inhibition exerted by the antibody abciximab and the peptidomimetic tirofiban. High fibrinogen concentrations reduced platelet inhibition by tirofiban, assessed in whole blood (r = -0.85, n= 10, p <0.01) and in platelet rich plasma (r = -0.89, n = 10, p <0.01) through PFA 100 and Born's aggregometry assay, respectively. Both drugs were unaffected by von Willebrand factor levels, while platelet count was inversely related to their inhibitory effect (tirofiban: r = -0.9, n = 7, p

AB - Glycoprotein (Gp) IIb/IIIa blockers are powerful antithrombotic agents, but display a wide variability of their effect using weight-adjusted dosing. We investigated whether some hemostatic variables affected in vitro platelet inhibition exerted by the antibody abciximab and the peptidomimetic tirofiban. High fibrinogen concentrations reduced platelet inhibition by tirofiban, assessed in whole blood (r = -0.85, n= 10, p <0.01) and in platelet rich plasma (r = -0.89, n = 10, p <0.01) through PFA 100 and Born's aggregometry assay, respectively. Both drugs were unaffected by von Willebrand factor levels, while platelet count was inversely related to their inhibitory effect (tirofiban: r = -0.9, n = 7, p

KW - Fibrinogen

KW - GpIIb-IIIa blockers

KW - Inhibition

KW - Platelet

KW - Receptor occupancy

UR - http://www.scopus.com/inward/record.url?scp=0037329144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037329144&partnerID=8YFLogxK

M3 - Article

C2 - 12574816

AN - SCOPUS:0037329144

VL - 89

SP - 348

EP - 354

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 2

ER -